Guide to Selection of Fluoroquinolones in Patients with Lower Respiratory Tract Infections

Newer fluoroquinolones such as levofloxacin, moxifloxacin, gatifloxacin and gemifloxacin have several attributes that make them excellent choices for the therapy of lower respiratory tract infections. In particular, they have excellent intrinsic activity against Streptococcus pneumoniae, Haemophilus...

Descripción completa

Detalles Bibliográficos
Autores principales: Shams, Wael E., Evans, Martin E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7100689/
https://www.ncbi.nlm.nih.gov/pubmed/15892589
http://dx.doi.org/10.2165/00003495-200565070-00004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7100689/
https://www.ncbi.nlm.nih.gov/pubmed/15892589
http://dx.doi.org/10.2165/00003495-200565070-00004

Ejemplares similares